Brief: Ascelia Pharma Oct-Dec Operating Loss Widens To SEK 22.9 Mln
Feb 14 (Reuters) - Ascelia Pharma AB ACELP.ST :
* 2019 YEAR-END FINANCIAL REPORT: SITES OPENED FOR
RECRUITMENT TO
THE PIVOTAL PHASE III STUDY SPARKLE
* OCT-DEC OPERATING RESULT OF SEK -22.9M (SEK -7.2M)
* OCT-DEC CASH FLOW FROM OPERATIONS OF SEK -16.8M (SEK
-9.1M)
Source text for Eikon: ID:nWkr2yzhmg
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))